Stocks to Watch: Stocks expected to move Wednesday (at MarketWatch)A look at companies whose shares are expected to see active trade in Wednesday’s session.
ADC Shares Rise Following 4Q Earnings (AP)Shares of ADC Telecommunications Inc. rose after an early decline Wednesday morning, a day after the telecom equipment maker posted its fourth-quarter results, warning its first-quarter sales will likely fall below Wall Street’s estimates.
Aftermarket Movers: Cooper Cos. Crashes (AP)A handful of earnings reports generated the most action in the aftermarket session Tuesday, with eye care product maker Cooper Cos. among the biggest movers.
Indications: Stock futures rise on strong retail sales; Continental, UAL gain (at MarketWatch)U.S. stock futures rallied Wednesday, with gains accelerating after the release of stronger-than-expected retail sales data.
Telecom Stocks: Telecom stocks gain; Level 3 in deal (at MarketWatch)Level 3 Communications Inc. announced its sixth acquisition of 2006 to highlight trading on Tuesday in an otherwise quiet telecommunications sector.
ADCT Stock Investing | ADCT>Google Finance ADCT | ADCT>Yahoo Finance ADCT
Analysts See More Biotech M&A in 2007 (AP)Who will be the next biotech takeover target? That’s the question Wall Street is asking as a year of innovative developments and heated competition in several of the industry’s markets draws to a close.
Amylin’s Byetta OK’s for Expanded Use (AP)Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said Friday the Food and Drug Administration approved their diabetes drug Byetta for additional use to help improve blood sugar levels in type-2 diabetes patients.
FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use (PR Newswire)Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the U.S. Food and Drug Administration has approved BYETTA injection as an add-on therapy to improve blood sugar control in people with type 2 diabetes who have not achieved adequate control on a thiazolidinedione .
Amylin Chairman Exercises Options (AP)The chairman of Amylin Pharmaceuticals Inc., which specializes in drugs for the treatment of diabetes, obesity and cardiovascular disease, exercised options for 15,000 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing Friday.
Top Ten: The week’s top news and analysis, Dec. 4-8 (at MarketWatch)Change swept the Pentagon and Yahoo. The financial-services sector saw the latest development in its long-running consolidation trend. A price was put on boardroom “pretexting.” OPEC appeared to draw a line in the sand.
AMLN Stock Investing | Google Finance AMLN | Yahoo Finance AMLN
Bristol to seek approval of three new cancer drugs next year (at CNNMoney.com)Drugmaker says it will seek approval for drugs aimed at treating melanoma, breast cancer and bladder cancer.
Ipilimumab (MDX-010) Safety and Clinical Response Data in Lymphomas and Leukemia Presented at the 48th American Society of Hematology Annual Meeting (PR Newswire)Medarex, Inc. today announced safety and response data in patients treated with ipilimumab for lymphomas and leukemia from two separate Phase I and Phase I/II clinical trials.
Pfizer Shares Sink After Key Drug Halted (AP)Pfizer Inc.’s decision to scrap development of a crucial medicine sent its shares plummeting Monday as analysts fretted about its future and speculated about which companies it might purchase to shore up its pipeline.
Biotech Stocks: Pfizer leads drug gainers (at MarketWatch)Pfizer Inc. led pharmaceutical gainers on Thursday, as the world’s largest drug maker raised its forecast for the year and said it expects its late-stage drug pipeline to increase “dramatically” in the coming years.
Medarex Receives NASDAQ Notice Regarding Delayed Filing of Form 10-Q (PR Newswire)Medarex, Inc. today announced that it has received an anticipated NASDAQ Staff Determination letter on November 13, 2006, notifying Medarex that it was not in compliance with NASDAQ Marketplace Rule 4310 because Medarex had not timely filed its Quarterly Report on Form 10-Q for the period ended September 30, 2006.
MEDX Stock Investing | Google Finance MEDX | Yahoo Finance MEDX
Strategies: A New Way to Gauge a Start-Up?s WorthAndrew Metrick calls his new approach a ?reality check model.?
Your Money: It?s O.K. to Fall Behind the Technology CurvePaying less in the future for a device that can do more is now taken for granted when shopping for consumer electronics.
Mitsubishi Heavy, GE to tie up on power: NikkeiTOKYO (Reuters) - Japan’s Mitsubishi Heavy Industries Ltd. and U.S. conglomerate General Electric Co. are set for a tie-up on nuclear and wind power generation, the Nihon Keizai Shimbun (Nikkei) reported on Saturday.
Top Picks 2007: Technician tunes in XM Satellite
Filed under: XM Satellite Radio (XMSR), Newsletters, Top Picks 2007
Each year Steven Halpern, editor of TheStockAdvisors.com, surveys the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is part of his 24th annual Top Picks Report.
XM Satellite Radio (NASDAQ: XMSR) is a favorite speculative idea from technician Jack Rothstein, editor of Wealthcast. He explains, “We had viewed a move above $15.50 on a closing basis as a buy signal for XMSR and a necessary technical step to keep the current move into a new advance alive.
“The stock traded above that point right and is bullish on all cylinders, having busted through its declining 200-day moving average at 15.09. Technically, the stock is now free to move to 20 and challenge that level.
“When it happens is merely a guess. It will happen now that it broke through necessary points of resistance. It ought to be bought from current levels down to support at 15.25. If you believe in it, then you will give it room all the way down to 13.49 to stop the loss in case it fails.
“However, that doesn’t appear to be in the cards right now. The stock appears to be firing on all cylinders and has blasted through to begin a new advance after building a decent base over the past 5 months after bottoming out.
“The bottom came in July after a brutal decline took it from a peak of 40.89, exactly two years ago, to fall to 9.63. It’s in a new advance and ought to be held long. Overall, XMSR is my number one choice for 2007.”
To see Jack’s favorite conservative idea for 2007, click here.
Permalink | Email this | Comments
Following 007 takes courage - but here goes!
Filed under: Forecasts, Rants and raves, Time Warner (TWX), Home Depot (HD), China, Market matters, Getting started, Next big thing, Columns, Duke Energy (DUK), Dow Chemical (DOW), Top Picks 2007, Valero Energy (VLO), PetroChina Co Ltd ADR (PTR), Huaneng Power Intl ADS (HNP)
Yesterday I put my reputation on the line by recommending seven stocks that I think will outperform the market in 2007, You don’t have to be 007 to find the best picks for 2007!. In the past few years I have made some great calls and doubled, sometimes even tripled the market averages, helped along by stocks like PetroChina, (NYSE: PTR) acquired for $44 and closing yesterday $142.12; Intuitive Surgical (NASDAQ: ISRG) acquired at $7.70 and closing yesterday at $96.73; Merck (NYSE: MRK) acquired at $32.00 rising to $43.55, and Time Warner Inc. acquired at $12.10 and settling in last night at $22.00. There were many others.
This all followed the same disastrous 2001 collapse that most investors suffered. I wish I would have listened to James Cramer when he told me in a personal email that telecom stocks were going down hard. Like any of us, he is not always right — but he was way right about that!
It has been said, and is worth repeating,“experience is what you get when you were expecting something else.” We all got way too much experience in 2001. Since that time I have recovered all of my losses and then some, but it took a lot of work, a lot of study, and certainly some luck. Let’s just say I’m older and wiser.
In making yesterday’s recommendations I tried to stay away from get rich quick notions and chose stocks that I believe have strong upside potential with protection against downside risk. All seven of my 2007 picks are well known companies to most stock market investors. They are all companies that I feel are buy and hold propositions.
Here are the closing prices as of December 28, 2006 of the seven stocks I recommended:
- The Dow Chemical Company (NYSE: DOW): $40.02
- Duke Energy (NYSE: DUK): $33.02
- The Home Depot Inc. (NYSE: HD): $39.73
- Huaneng Power International ADS (NYSE: HNP): $36.00
- PetroChina ADR (NYSE: PTR): $142.12
- Time Warner Inc. (NYSE: TWX) $22.00
- Valero Energy (NYSE: VLO) $51.61
I will report back each month with the closing stock price as of the 28th of each month. If I am wrong it will be very public. Although I did not recommend jumping in each of these stocks at these prices immediately, I will use them for tracking purposes, come what may.
Disclosure: I own shares of DUK, HNP, PTR, TWX and will likely own DOW, HD, and VLO prior to next months report.
Happy New Year!
Check out my other posts for BloggingStocks here.
Sheldon Liber is the CEO of a small private investment company and the vice president for design and research at an architecture & planning firm.
Permalink | Email this | Comments
Stock Investing
TurboTax maker Intuit to buy Digital Insight for $1.35B (at CNNMoney.com)Intuit announces deal to purchase Digital Insight for $1.35 billion, hoping to broaden reach into banking industry.
Law Offices of Shawn Khorrami and Kabateck Brown Kellner File Wrongful Death/Mass Action Suits Against Birth Control Patch (Market Wire)A wrongful death lawsuit involving a 26-year-old woman and a mass action suit on behalf of 55 women nationwide suffering from blood clots and other serious illnesses were filed today in California State Court in San Francisco.
McKesson renews Wal-Mart supply deal (bizjournals.com)McKesson Corp. said it renewed its supply agreement with Wal-Mart Stores Inc., the nation’s largest retailer.
McKesson Renews Pharmaceutical Distribution Agreement With Wal-Mart (Business Wire)SAN FRANCISCO—-McKesson Corporation , the nation’s largest pharmaceutical distributor, announced today that it has renewed its comprehensive supply agreement with Wal-Mart Stores, Inc., the largest retailer in the world.
MCK Stock Investing | Google Finance MCK | Yahoo Finance MCK